© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Formulary
FDA Update: Report Claims “Power Grab,” Dems Say Hahn Blocked From Testifying
September 20, 2020
Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.
The Challenges of Treating Primary Progressive MS
September 13, 2020
A session at MSVirtual2020 covers the difficulty of finding treatments for some forms of MS.
5 Takeaways From the European Society of Cardiology 2020 Congress
September 02, 2020
The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.
Electronic Prior Authorization is Catching on
August 27, 2020
But there are plenty of holdouts. Half of submissions are still done by phone or fax.
ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1
August 08, 2020
Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.
An Update for Cardiologists Who See Patients With Type 2 Diabetes
August 05, 2020
The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.
5 Tips for Employers on Reforming and Optimizing Medication Use
August 04, 2020
Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.
Is the Biosimilars Waiting Game Finally Over?
July 30, 2020
Advocates say a number of regulatory changes could help bring more of these products on to the market.
Heart Drug Updates: Fast Track for Farxiga after MI, Brilinta Plus Aspirin After Stroke or TIA, NDA for Vericiguat
July 18, 2020
Heart disease drugs were in the news this week.
FDA Updates: Brilinta’s Priority Review in Stroke; Biogen’s Alzheimer’s BLA; Mytesi IND in Cancer Care
July 11, 2020
Drug development in key areas of unmet need hit milestones this week, with Biogen, AstraZeneca, and Jaguar Health announcing regulatory steps with the FDA.
Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners
July 05, 2020
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations
June 30, 2020
FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.
5 Developments Changing the CAR-T Landscape
June 28, 2020
An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.
Out-of-Pocket Costs for Diabetes Medicine Eliminated
January 31, 2020
New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.
Top Issues Facing Pharma in 2020
January 11, 2020
Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.
Will Outcomes-Based Payments Hit COPD Drugs?
November 29, 2018
In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?
Will Drug Price Hikes Impact Drug Spending?
November 28, 2018
Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.
How Payers are Responding to Growing Orphan Drug Costs
April 26, 2018
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causes
November 07, 2017
Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.